Hypothalamic pro-opiomelanocortin (POMC) neurons promote satiety. Cannabinoid receptor 1 (CB 1 R) is critical for the central regulation of food intake. Here we test whether CB 1 R-controlled feeding in sated mice is paralleled by decreased activity of POMC neurons. We show that chemical promotion of CB 1 R activity increases feeding, and notably, CB 1 R activation also promotes neuronal activity of POMC cells. This paradoxical increase in POMC activity was crucial for CB 1 R-induced feeding, because designer-receptors-exclusively-activated-by-designer-drugs (DREADD)-mediated inhibition of POMC neurons diminishes, whereas DREADD-mediated activation of POMC neurons enhances CB 1 Rdriven feeding. The Pomc gene encodes both the anorexigenic peptide a-melanocyte-stimulating hormone, and the opioid peptide b-endorphin. CB 1 R activation selectively increases b-endorphin but not a-melanocyte-stimulating hormone release in the hypothalamus, and systemic or hypothalamic administration of the opioid receptor antagonist naloxone blocks acute CB 1 R-induced feeding. These processes involve mitochondrial adaptations that, when blocked, abolish CB 1 R-induced cellular responses and feeding. Together, these results uncover a previously unsuspected role of POMC neurons in the promotion of feeding by cannabinoids.
, whereas POMC-producing neurons promote satiety 4 . Homeostatic feeding regulation can be disrupted by exogenous substances, such as cannabinoids 5 . Activation of CB 1 R can lead to robust feeding despite animals being sated 6 . However, the role of cannabinoids in the control of hypothalamic feeding circuits remains enigmatic [5] [6] [7] [8] [9] [10] . In this study, we interrogated whether CB 1 R-mediated feeding in a satiety state is associated with suppressed activity of POMC neurons, and if so, whether the altered activity of these neurons is important for CB 1 R-induced feeding.
CB 1 R drives activation of POMC neurons
We found that the selective CB 1 R agonist arachidonyl-29-chloroethylamide (ACEA) induced a known 11 bimodal feeding response in fed mice (Extended Data Fig. 1a-c) . Notably, hyperphagic stimulation of CB 1 R resulted in activation of POMC neurons, as assessed by expression of the proto-oncogene cFOS (Fig. 1A, B) . Ex vivo electrophysiological recordings from ACEA-treated mice confirmed POMC neuronal activation (Fig. 1C) . Next, we analysed slices acutely treated with ACEA. In the presence of tetrodotoxin (TTX), which blocks action potentials, ACEA failed to directly alter the membrane current of POMC neurons (Fig. 1D, a) . We found that without TTX, low doses of ACEA (200 nM) induced depolarization of POMC neurons (Fig. 1D, b) , as reported earlier 12 , whereas high ACEA doses (1 mM) resulted in hyperpolarization of POMC cells (Fig. 1D, c) . As an anatomical substrate of these effects, we detected CB 1 R immunolabelling in both GABAergic and glutamatergic presynaptic terminals of POMC neurons (Fig. 1D, d ). In line with these findings, hyperphagic doses of CB 1 R agonists ACEA or WIN-55,212-2 mesylate (hereafter referred to as WIN) (1 mg kg 21 body weight) induced cFOS expression in POMC neurons (Fig. 1E) . By contrast, the ACEA dose that did not affect food intake (5 mg kg 21 body weight) also did not induce cFOS expression in POMC neurons (Fig. 1E) .
ACEA injected into the ARC resulted in a feeding response similar to that seen after its peripheral injection (Extended Data Fig. 1d ). This local ACEA injection also activated POMC neurons as assessed by expression of phosphorylated CREB (pCREB(Ser 133)) and cFOS immunolabelling (Fig. 1F, G) . Administration of the inverse CB 1 R agonist rimonabant (RIMO) into the ARC blocked stimulation of food intake by peripheral ACEA application (Extended Data Fig. 1e-g ), and, RIMOmediated CB 1 R blockade augmented the inactivation of POMC neurons in fasted mice as assessed by cFOS expression (Fig. 1H, I and Extended Data Fig. 1h ).
POMC neurons drive feeding by cannabinoids
To determine whether the paradoxical POMC neuronal activation triggered by CB 1 R is relevant for feeding, we injected inhibitory or stimulatory DREADD (AAV-hM4Di-mCherry or AAV-hM3Dq-mCherry 3 ) into the ARC of Pomc-Cre mice (Extended Data Fig. 2a, b) .
Clozapine-N-oxide (CNO)-driven activation of inhibitory DREADD reduced the numbers of cFOS-immunolabelled neurons in the ARC (Extended Data Fig. 2c ), and blocked ACEA-induced activation of POMC neurons in fed mice (Extended Data Fig. 2d, e) . CNO-mediated inhibition of POMC neurons in vehicle-treated mice enhanced feeding 8 h after CNO administration (Extended Data Fig. 2f ). Conversely, DREADD-mediated activation of POMC neurons in vehicle-treated mice suppressed feeding 8 h after CNO application (Extended Data Fig. 2g ). These findings are in line with previous observations that ARC POMC neurons gradually suppress feeding behaviour 4, 13 . By contrast, DREADD-induced inhibition of POMC neurons significantly reduced acute, cannabinoid (WIN or ACEA)-induced feeding ( Fig. 2a-d) , whereas the acute hyperphagic response to the CB 1 R agonist ACEA was significantly amplified by DREADD-induced activation of POMC neurons (Fig. 2e, f) . Thus, our results demonstrate that POMC neuronal activation is key for feeding evoked by CB 1 R in sated mice.
CB 1 R drives b-endorphin but not a-MSH release
The Pomc gene encodes both the anorexigenic peptide a-melanocytestimulating hormone (a-MSH) and the opioid peptide b-endorphin, which can be orexigenic [14] [15] [16] . The hypothalamic paraventricular nucleus (PVN) is the main site where efferents of POMC neurons are thought to affect feeding 1, 17, 18 . ACEA-mediated activation of CB 1 R did not affect a-MSH levels (Extended Data Fig. 3a -d, i and Extended Data Table 1a ), but it was correlated with increased b-endorphin levels in the PVN 7 (Extended Data Fig. 3e -h, j and Extended Data Table 1b ). In line with this, ACEA triggered the secretion of b-endorphin but not a-MSH into the supernatant of acute mediobasal hypothalamic explants derived from fed mice (Fig. 3a) .
Next, we blocked CB 1 R in the ARC by local injection of RIMO, which diminished ACEA-induced b-endorphin secretion (Fig. 3b) . ACEA-induced b-endorphin secretion was absent in CB 1 R knockout (Cnr1 2/2 ) mice (Fig. 3b) . ACEA affected b-endorphin levels in a dosedependent manner (Extended Data Fig. 4a and Extended Data Table 2) , and local injection of ACEA into the ARC robustly induced b-endorphin levels in the PVN (Extended Data Fig. 4b , c and Extended Data Table 3) .
a-MSH and b-endorphin are derived from POMC by pro-protein convertases, including PC-1 and PC-2 (ref. 14) . CB 1 R activation did 21 body weight ACEA, n 5 3, 29.8 6 2.6%; *P , 0.05 versus vehicle (one-way analysis of variance (ANOVA) followed by Dunnett's multiple comparisons test). NS, not significant (P . 0.05). F, G, Local ARC hyperphagic CB 1 R activation induced pCREB(Ser 133) (vehicle, n 5 4 mice, 35.2 6 2.2%; ACEA, n 5 5, 55.8 6 3%) and cFOS (vehicle, n 5 5, 38.7 6 5.4%; ACEA, n 5 5, 65.8 6 4.8%; **P , 0.01) expression in POMC cells. H, I, In the fasted state, RIMO decreased POMC cFOS expression (vehicle, n 5 6 mice, 12.1 6 2.8%; RIMO, n 5 6, 3.6 6 1.9%; *P , 0.05; two independent experiments). All values (biological replicates: A, B, D, d, E-I; biological replicates including technical replicates: C, D, a-c) denote mean 6 s.e.m. POMC cFOS expression analyses in fed mice were performed in three independent experiments using litters from different parents (A, B, E-G). P values (unpaired comparisons) by two-tailed Student's t-test, unless otherwise stated. Scale bars, 25 mm (A, D, d, H) and 50 mm (F).
RESEARCH ARTICLE
not affect transcriptional regulation of either of these convertases (Pcsk1 and Pcsk2, respectively; Extended Data Fig. 5a, b) , but it did increase protein levels of PC-1 and PC-2 (Fig. 3c, d and Extended Data Fig. 5c ).
Differential release dynamics of b-endorphin and a-MSH suggest that they may be present in non-overlapping intracellular compartments of POMC neurons. We observed that immunolabelling of these peptides did not overlap in 33.5 6 4.6% (mean 6 s.e.m.) of POMC boutons in the PVN (Fig. 3e) . With electron microscopy, we confirmed that b-endorphin and a-MSH could be found in separate vesicles within the same neuronal profile of the PVN (Fig. 3f) . Thus, our data indicate that separate vesicle pools of b-endorphin and a-MSH are under diverse regulatory mechanisms.
Naloxone blocks cannabinoid-induced feeding
Previous findings showed that local infusion of b-endorphin into the PVN could induce hyperphagia 19, 20 . In fed mice, the m-opioid receptor antagonist naloxone (NALO; 7.5 mg kg 21 body weight, intraperitoneal)
diminished CB 1 R-dependent hyperphagic response of WIN ( Fig. 3g) and ACEA (Fig. 3h ). Central application of naloxone into the PVN also diminished ACEA-and WIN-evoked hyperphagia (Fig. 3i ). b-endorphin was shown to be a feed-forward presynaptic inhibitor of AgRP neuronal activity 4 . In line with this, 90 min after ACEA application, the action potential frequency of AgRP neurons was decreased (Fig. 3j) .
Taken together, we conclude that CB 1 R-induced acute feeding in sated mice is evoked by POMC neurons via b-endorphin release and m-opioid receptor activation while AgRP neurons are silenced.
CB 1 R induces mitochondrial adaptations
Next we explored intracellular mechanisms that may bring about changes in neuropeptide release properties of POMC cells. Real-time PCR revealed local ARC CB 1 R (Cnr1) expression (Fig. 4a) . Immunolabelling for CB 1 R showed both presynaptic and intracellular localization of CB 1 R in POMC neurons (Fig. 4b, c) . Electron microscopy revealed the presence of CB 1 R immunoreactivity in mitochondria of POMC cells ( Fig. 4d and Extended Data Fig. 5e ), a finding consistent with previous observations of CB 1 R in mitochondria of neurons [21] [22] [23] [24] [25] . Dynamic changes of mitochondria-endoplasmatic-reticulum (ER) contacts were shown in POMC neurons in association with changes in their activity and metabolic milieu 26, 27 . In line with this, we found that hyperphagic activation of CB 1 R resulted in an increased number of mitochondria-ER contacts ( Fig. 4e-g ). We also observed that ACEA-mediated activation of CB 1 R dose-dependently increased hypothalamic coupled (state 3) and uncoupled (state 4) mitochondrial respiration ( Fig. 4h-j) . Increased coupled mitochondrial respiration is associated with increased generation of reactive oxygen species (ROS), which we showed previously to increase POMC neuronal activity 28 . Indeed, we found that hyperphagic ACEA administration increased ROS levels in POMC neurons (Fig. 5a, b) .
CB 1 R-induced energetic switch relies on UCP2
ROS are known to induce the expression and function of mitochondrial uncoupling protein 2 (UCP2) 29, 30 , a regulator of hypothalamic mitochondrial respiration and feeding 31, 32 . Hyperphagic activation of CB 1 R by ACEA increased hypothalamic expression of Ucp2 messenger RNA (Fig. 5c) . ACEA failed to alter mitochondrial respiration in the hypothalamus of UCP2 knockout mice (Ucp2 2/2 ; Fig. 5d ). CB 1 R-induced changes in POMC, PC-1 and PC-2 were diminished in Ucp2 2/2 mice (Fig. 5e-g and Extended Data Fig. 6c ). Whereas CB 1 R-driven POMC neuronal activation was partially retained (Fig. 5h) , neither CB 1 Rassociated feeding (Fig. 5i) nor CB 1 R-dependent increase of b-endorphin ( Fig. 5j and Extended Data 
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Thus, we conclude that UCP2 has a critical role in mediating CB 1 R action on intracellular adaptation of POMC neurons while promoting feeding.
Discussion
Since the discovery of the melanocortin system and its satiety promoting action via melanocortin 4 receptors [33] [34] [35] , POMC neurons have been considered as key drivers of the cessation of feeding [35] [36] [37] . However, our findings unmasked an overlooked, albeit previously proposed 16, 38 role for hypothalamic POMC neurons in the promotion of feeding. Specifically, we found that POMC neuronal activation is indispensable for appropriate promotion of feeding triggered by CB 1 R activation in the state of satiety. This observation brings these neurons to a new light in feeding regulation.
Cannabinoid-controlled feeding behaviour is complex and probably relies on diverse modes of action 11, 39 . We focused on a specific action of cannabinoids, which is acute feeding evoked by CB 1 R activation during the time of satiety. Thus, it is not unlikely that the cellular biological principles we uncovered here involving CB 1 R action are not ubiquitous throughout the brain relating to cannabinoids. Nevertheless, the phenomenon of cannabis-triggered feeding in a state of satiety is a hallmark of marijuana use in humans 40, 41 , and whether hypothalamic POMC neurons may be relevant to other aspect of the complex behavioural responses triggered by cannabis use will be important to address.
We found that cannabinoid-induced activation of POMC neurons and related feeding relies on both pre-synaptic modalities and mitochondrial mechanisms. Regarding the presynaptic events, it is intriguing to note that CB 1 R activation had a bimodal effect, in which lower doses of the CB 1 R agonist ACEA induced depolarization of POMC neurons, while higher doses hyperpolarized these cells. Because both GABAergic and glutamatergic pre-synaptic terminals on POMC neurons expressed CB 1 R, it is reasonable to assume that the bimodal effect of cannabinoids on feeding are due to the differential sensitivity of GABAergic versus glutamatergic axons to CB 1 R activation 10, 11 . The effect of CB 1 R on mitochondria, and the mitochondrial localization of CB 1 R are both in line with the original observations on CB 1 R action in other brain sites 23 . In the present study, we showed that this CB 1 R-dependent mitochondrial adaptation relies on the mitochondrial protein UCP2. UCP2 has been associated with hypothalamic feeding circuits 31, [42] [43] [44] , and was implicated in the malfunctioning of POMC neurons in diet-induced obesity 43 . However, most of those studies tied UCP2 activity to lipid and glucose use of hypothalamic neurons 32 . Here, we ) mice (n 5 4, 247.8 6 9.9; *P , 0.05, one-way ANOVA, followed by Dunnett's multiple comparisons test). c, d, ACEA increased hypothalamic PC-1 (c) and PC-2 (d) protein levels (all groups n 5 4 mice; PC-1: vehicle, 1.00 6 0.03; ACEA, 1.31 6 0.04; ***P , 0.001; PC-2: vehicle, 1.00 6 0.18; ACEA, 2.16 6 0.26; *P , 0.05). e, Overview (top) and magnification (bottom) of a-MSH (green) and b-endorphin (red) in POMC fibres in the PVN. Coloured arrows indicate non-overlapping immunolabelling (images are representative of three independent experiments). f, Electron micrograph showing peroxidase immunolabelling of b-endorphin (red arrow) and immunogold labelling of a-MSH (green arrow) in different vesicles of the same process (images are representative of three independent experiments). g, h, Peripheral administration of NALO (7.5 mg kg 21 body weight, intraperitoneal) blocked hyperphagia induced by WIN (g; vehicle plus vehicle, n 5 10 mice, 0.03 6 0.02; vehicle plus WIN, n 5 10, 0.21 6 0.03; NALO plus vehicle, n 5 8, 0.03 6 0.01, NALO plus WIN, n 5 10, 0.07 6 0.02; ***P , 0.001, #P , 0.05 for interaction of NALO and WIN; two-way ANOVA followed by Šidák's multiple comparisons test; two independent experiments) or induced by ACEA (h; vehicle plus ACEA, n 5 4, 0.36 6 0.05; NALO plus ACEA, n 5 4, 0.17 6 0.05; *P , 0.05). i, PVN NALO application (5 mg per 0.5 ml) blocked hyperphagia induced by ACEA (intraperitoneal; vehicle plus vehicle, n 5 5, 0.07 6 0.03; vehicle plus ACEA, n 5 5, 0.17 6 0.02; NALO plus VEHI, n 5 6, 0.08 6 0.02; NALO plus ACEA, n 5 6, 0.08 6 0.02; *P , 0.05, #P , 0.05 for interaction of NALO and ACEA; two-way ANOVA, followed by Šidák's multiple comparisons test; two independent experiments) or induced by WIN (intraperitoneal; vehicle plus WIN, n 5 6, 0.22 6 0.02; NALO plus WIN, n 5 7, 0.14 6 0.02; *P , 0.05; Hoechst (blue) injection for verification of correct cannula placement). j, Hyperphagic ACEA decreased AgRP/NPY-hrGFP (NPY-hrGFP) action potential (AP) frequency (vehicle, n 5 20 cells per 6 mice, 1.65 6 0.27 Hz; ACEA, n 5 20/6, 0.84 6 0.24 Hz; *P , 0.05; six independent experiments using litters from different parents). All values (biological replicates: a-i; biological replicates including technical replicates: j) denote mean 6 s.e.m. P values (unpaired comparisons) by two-tailed Student's t-test, unless stated otherwise. Scale bars, 25 mm (e, top), 5 mm (e, bottom), 1 mm (f) and 25 mm (i). mice. h, cFOS expression in POMC neurons induced by ACEA in wild-type mice (vehicle, n 5 4 mice, 22.1 6 6.2%; ACEA: 30 min, n 5 5, 39.6 6 3%; 90 min, n 5 3, 63.1 6 5,5%; 150 min, n 5 3, 57.2 6 2.6%; 180 min, n 5 3, 38.5 6 2.2%; *P , 0.05 versus vehicle, ***P , 0.001 versus vehicle; one-way ANOVA, followed by Dunett's multiple comparisons test) and Ucp2
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: a-d, h-j; biological replicates including technical replicates: e-g) denote mean 6 s.e.m. P values (unpaired comparisons) by two-tailed Student's t-test, unless stated otherwise. Scale bars, 25 mm (b, c), 0.5 mm (d) and 1 mm (e, f).
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littermates (vehicle, n 5 6 mice, 22.6 6 3.6%; ACEA: 30 min, n 5 6, 42.2 6 6.4%; 90 min, n 5 6, 36.6 6 3.1%; 150 min, n 5 3, 37.3 6 1.6%; 180 min, n 5 3, 33.5 6 5.2%; *P , 0.05 versus vehicle (one-way ANOVA, followed by Dunnett's multiple comparisons test); #P , 0.05 versus wild type 90-min ACEA (unpaired comparisons by multiple t-tests, followed by correction for multiple comparisons using Holm-Šidák's method). i, ACEA (2 h)-induced hyperphagia in wild-type mice (vehicle, n 5 10 mice, 0.04 6 0.01 g; ACEA, n 5 11, 0.14 6 0.03 g; *P , 0.05) but not in Ucp2 Table 4 for values; *P , 0.05, **P , 0.01). Values denote mean 6 s.e.m.
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identified UCP2 mediation as being crucial for the switch from a-MSH to b-endorphin release by POMC neurons triggered by CB 1 R activation. This suggests a novel function of UCPs in the central nervous system in which they control the release of specific vesicle pools of neuropeptides in POMC neurons. Whether this effect of UCP2 is specific to POMC cells or represents a novel regulatory principle for other neuronal populations that express UCP2, including the midbrain dopamine system 45 , needs to be explored. It is well known that a single neuron can have the capability of generating and releasing different types of neuropeptides 46 . How these different molecules with diverse functions are controlled within the same cells has not been fully resolved 46, 47 . Our findings raise the possibility that changes in mitochondrial functions may be critical regulators of these processes.
In summary, the overall effect of cannabinoids on feeding seems to be driven by both pre-and post-synaptic effects, which may be independent from one another, and it is their temporal synchrony that brings about the overall behavioural changes.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper.
METHODS
All used mice were aged between 10 and 18 weeks at the time of killing. All procedures were approved by Yale University Institutional Animal Care and Use Committee (IACUC). Mice were maintained under standard laboratory conditions with water and food freely available unless otherwise stated. Mice were housed on a 12 h light/12 h dark cycle with lights on at 07:00 and off at 19:00. All experimental groups within one experiment contained mice of same strain and sex, being similar in age and body weight, showing no difference in physical activity and feeding behaviour when assessed before drug injections. Starting at 13-14 weeks of age, body weights differed between wild-type and Cnr1 2/2 littermates. Animals from different experimental groups (vehicle versus drug treatment) were randomly allocated within the experimental order. After finishing experiments (data collection), each mouse ID was modified by a second investigator to blind the respective investigator who performed data analyses. Mice. Pomc topaz (Pomc-GFP) transgenic mice were provided by J. Friedman and generated as described earlier 48 . The Npy-hrGFP line (strain B6.FVB-Tg (Npy-hrGFP) 1Lowl/J) and Pomc-Cre line (strain Tg (Pomc1-cre) 16Lowl/J) were purchased from The Jackson Laboratories. Pomc-GFP and Npy-hrGFP lines are maintained on a C57BL6 background; the Pomc-Cre line is maintained on a mixed background in our laboratory. Note that Npy-hrGFP mice allow visualization of AgRP neurons through co-expression of NPY and AgRP in these cells. The first CB 1 R knockout (Cnr1
2/2
) line used here, as maintained in a C57BL6 background, was generated (sponsored by NIMH) and genotyped as previously described 49 . This line was used for feeding studies (Extended Data Fig. 1c ) and ELISA experiments (Fig. 3b) . For generation of the second Cnr1 2/2 line used here, mice bearing the transcription blocking cassette flanked by loxP sites upstream of the Cnr1 start codon (Cnr11/ TB-flox) were crossed with transgenic mice expressing Pomc-Cre. Offspring expressing Cnr1TB/1, Pomc-Cre were mated with Cnr1TB/1 to obtain littermate controls (wild-type; Pomc-Cre::Cnr11/1 and Cnr11/1), CB 1 R knockout controls (TB-CB 1 R; Cnr1TB/TB), and mice expressing CB 1 R only in POMC neurons (CB1RPOMC; Pomc-Cre::Cnr1TB/TB). These mice were used for specification of POMC CB 1 R expression and for validation of CB 1 R antibody specificity (Extended Data Fig. 5e ). The original breeding pairs of the UCP2 knockout (Ucp2 2/2 ) line were provided by B. Lowell and were generated as reported previously 50 . C57BL6 mice were purchased from The Jackson Laboratories. Chemicals and antibodies. The selective CB 1 R agonist arachidonoyl 2-chloroethylamide (ACEA; Tocris Biosciences) was delivered pre-dissolved in ethanol (5 mg ml
21
). For central injection of ACEA, ethanol was evaporated and ACEA was re-dissolved in dimethylsulfoxide (DMSO). The CBR agonist WIN-55,212-2 mesylate (WIN) and the CB 1 R inverse agonist rimonabant (RIMO; Cayman Chemical Company) were dissolved in DMSO and aliquots were stored as a stock solution of 10 mg ml 21 at 280 uC for 3 months or less. At the day of use, ACEA, WIN or RIMO was mixed with a small drop of Tween 80 (Sigma-Aldrich) before further dilution in saline and applied intraperitoneally to the animals. For the vehicle group, the same volume of ethanol or DMSO was applied compared to ACEA, WIN or RIMO. Clozapine-N-oxide (CNO; Enzo Life Sciences) was dissolved in saline (5 mg ml 21 ) and stored at 280 uC until day of use. The m-opioid receptor antagonist naloxone (naloxone hydrochloride; Tocris Bioscience) was dissolved in saline (100 mg ml 21 ) and stored at 280 uC until day of use. Dihydroethidium (DHE; 103 1 mg; Life Technologies) was stored light protected at 220 uC until use. Hoechst 33342 trihydrochloride, trihydrate (100 mg; Invitrogen) was stored light protected at 4 uC. Virus molecules (4 3 10 12 per ml, dialysed in 350 mM NaCl plus 5% D-sorbitol in PBS) containing inhibitory DREADD (rAAV5/EF1a-DIOhM4D(Gi)-mCherry) or stimulating DREADD (rAAV5/EF1a-DIO-hM3D(Gq)-mCherry) were purchased from Gene Therapy Center Vector Core. Aliquots were stored at 280 uC. The used primary and corresponding secondary antibodies were stored according to manufacturer's instructions. Primary antibodies are summarized in Supplementary Table 1 .
Immunofluorescence. After removal of food at 10:00, fed male mice were injected intraperitoneally with vehicle, WIN (1 mg kg 21 body weight) or ACEA (1 or 5 mg kg
) for 90 min. Overnight fasted male mice were injected (intraperitoneally) with vehicle or RIMO (3 mg kg 21 ) at 10:00 for 90 min. Mice were then anaesthetized by isofluorane and killed by perfusion fixation (4% paraformaldehyde (PFA) in 0.1 M PBS), followed by overnight post-fixation in 4% PFA. After 30 min washing in PBS, brains were cut into 50-mm-thick sections, and 12 sections per mouse containing the ARC were collected. After 15 min in PBS, the sections were incubated in blocking solution (1:20 normal donkey serum in PBS (in case of CB 1 R staining using antisera derived from guinea-pig, 1:20 normal goat serum was used), containing 0.2% Triton X-100) for 30 min at room temperature. Primary antibodies (see Supplementary Table 1) were then applied overnight at room temperature. The next day, sections were washed three times (5 min The anti-cFOS antibody was incubated at room temperature overnight. The next day, sections were incubated in biotinylated goat anti-rabbit IgG (dilution 1:250; BA-1000, Vector Laboratories) for 2 h at room temperature. After washing in PBS, sections were incubated in avidin, conjugated with Alexa Fluor 488 (dilution 1:2,500, A-21370, Life Technologies) for 1 h at room temperature. After washing in PBS, sections were incubated in unconjugated anti-rabbit IgG (dilution 1:25, 711-005-152, Jackson ImmunoResearch Laboratories) for 2 h at room temperature. After washing in PBS, the sections were incubated with anti-POMC antibody overnight at room temperature. Finally, sections were incubated with goat anti-rabbit Alexa Fluor 633 (dilution 1:750, A-21070, Life Technologies) in PBS for 1 h at room temperature. Confocal laserscanning microscopy was performed using a Zeiss LSM510 Meta, the confocal system equipped with helium neon lasers (543 and 633 nm excitation lines) and an argon laser (488 nm). Quantification of cFOS and pCREB immunoreactivity in Pomc-GFP and Pomc-Cre mice was performed by counting the percentage of cFOS-and pCREB-positive POMC-GFP or POMCimmunolabelled cells in 10-mm optical, confocal sections obtained from 50-mm-thick vibratome sections. For each mouse, at least 3-4 50-mm-thick sections containing the ARC were analysed. Immunocytochemistry for electron microscopy. Male C57BL6 mice were anaesthetized and transcardially perfused with 4% PFA and 0.1% glutaraldehyde. After post-fixation overnight, vibratome sections (50 mm) containing the ARC were immunostained. After overnight incubation of primary antibodies (see Supplementary Table 1) , sections were washed, incubated with biotin-conjugated donkey anti-rabbit IgG secondary antibody (dilution 1:250, 711-065-152, Jackson ImmunoResearch Laboratories) for 2 h, washed again, put in avidin-biotin complex (ABC; Vector Laboratories), and developed with 3,3-diaminobenzidine (DAB). After washing, sections were incubated in 6 nm colloidal gold-conjugated donkey ant-sheep IgG secondary antibody (dilution 1:50, 713-195-147, Jackson ImmunoResearch Laboratories) for 2 h. Sections were then osmicated (15 min in 1% osmium tetroxide) and dehydrated in increasing ethanol concentrations. During the dehydration, 1% uranyl acetate was added to the 70% ethanol to enhance ultrastructural membrane contrast. Flat embedding in Durcupan followed dehydration. Ultrathin sections were cut on a Leica ultra microtome, collected on Formvarcoated single-slot grids, and analysed with a Tecnai 12 Biotwin electron microscope (FEI). Semi-quantitative measurements of a-MSH and b-endorphin immunostaining. Analyses of a-MSH and b-endorphin immunosignals in male mice were performed by use of ImageJ 1.48 s software, following the online tutorial for area measurements and particle counting (http://imagej.nih.gov/ij/docs/pdfs/examples.pdf). In brief, confocal stack images (z-stacks; thickness/optical section: 6 mm, resolution: 1,024 3 1,024 pixels) of one side of the PVN were obtained from 50-mm-thick vibratome brain sections, using the same magnification and the same confocal microscope setup for all samples. All images from the different experimental groups in one experiment were taken within the same session at the confocal microscope (Zeiss LSM510 Meta). For z-projection, five optical sections from the middle area of each brain slice were used. Images were converted into greyscale (8 bit) and binary images were created. For particle analysis, the range of particle size (in pixel units) was set to resemble a-MSH and b-endorphin immunosignals in the PVN and to avoid selection of unspecific background staining. The same range of particle size was used for all samples. Finally, total numbers of selections ('number'), the sum of the size of all selections ('area'; in square pixels) and the sum of the average grey values of all selection ('mean' grey values) were calculated. Electrophysiology. Coronal hypothalamic slices containing the ARC of male Pomc-gfp or NPY-hrGFP mice (3-4 weeks old) were prepared 90 min after in vivo saline or ACEA (1 mg kg 21 body weight) treatment, as described previously 51 . In brief, mice were anaesthetized with isoflurane and decapitated, the brain was rapidly removed and immersed in a cold (4 uC) and oxygenated cutting solution containing (mM): sucrose 220, KCl 2.5, NaH 2 PO 4 1.23, NaHCO 3 26, CaCl 2 1, MgCl 2 6 and glucose 10 (pH 7.3 with NaOH). Coronal hypothalamic slices (300 mm thick) were cut with a Leica vibratome after the brain was trimmed to a small tissue block containing the hypothalamus. After preparation, slices were maintained at room temperature (23-25 uC) in a storage chamber in the aCSF (bubbled with 5% CO 2 and 95% O 2 ) containing (in mM): NaCl 124, KCl 3, CaCl 2 2, MgCl 2 2, NaH 2 PO 4 1.23, NaHCO 3 26, glucose 10 (pH 7.4 with NaOH) for recovery and storage. After recovery at room temperature for at least 1 h, slices were transferred to a recording chamber constantly perfused with bath solution (same as the aCSF except ARTICLE RESEARCH containing 2.5 mM glucose) at a temperature of 33 uC and a perfusion rate of 2 ml min 21 for electrophysiological experiments. Whole-cell patch-clamp recording was performed in Pomc-GFP and Npy-hrGFP neurons under current clamp with the methods previously reported 51 . Spontaneous membrane and action potential was recorded for 10 min in Pomc-GFP and Npy-hrGFP neurons from both control and ACEA-treated mice.
To test the effects of ACEA on POMC neurons in vitro, hypothalamic slices containing the ARC were prepared from naive male Pomc-GFP mice. After a stable recording of membrane and action potential under current clamp or membrane current under voltage clamp (at 260 mV), ACEA was applied, in the presence or absence of TTX (0.5 mM), to the recorded cells through bath application for 10 min. The micropipettes (4-6 MV) were made of borosilicate glass (World Precision Instruments) with a micropipette puller (Sutter P-97) and back filled with a pipette solution containing (mM): K-gluconate 135, MgCl 2 2, HEPES 10, EGTA 1.1, Mg-ATP 2.5, Na 2 -GTP 0.3, and Na 2 -phosphocreatin 10 (pH 7.3 with KOH). Both input resistance and series resistance were monitored throughout the experiments and the former was partially compensated. Only recordings with stable series resistance and input resistance were accepted. All data were sampled at 3-10 kHz, filtered at 3 kHz and analysed with an Apple Macintosh computer using AxoGraph X (Kagi).
Behavioural test (open field). A slightly modified experimental regimen according ref. 52 was used. The apparatus consists of a Plexiglas open field (37 3 37 3 37 cm). Male C57BL6 mice habituated for single cage housing and intraperitoneal injection (see 'food intake measurements'), were put in the open field for 90 min after injection with vehicle or ACEA (5 mg kg 21 body weight) and locomotor activity was monitored. Central cannula placement. Anaesthetized (in mg kg 21 body weight: intraperitoenal, 30 ketamine, 6 xylazine; subcutaneous; 0.1 buprenorphine) 10-week-old male C57BL6 or 12-week-old male Pomc-gfp mice were placed into a stereotaxic apparatus (model 902; David Kopf instruments). The head was cleaned with alcohol pads and incision was made with a sterile scalpel. To place the guide acute cannula (C315GA/SPC, 26 gauge, 8 mm pedestal size, 6.5 mm below pedestal; Plastics One), a single hole was drilled according to the following coordinates: ARC, bregma, anterior-posterior: 21.2 mm, lateral: 10.25 mm; PVN, bregma, anterior-posterior: 20.6 mm, lateral: 10.25 mm). The guided cannula was placed 1 mm dorsal to the region of interest to minimize damage of target area (ARC, bregma, dorsal-ventral: 25.0 mm, PVN, dorsal-ventral: 24.5 mm. The cannula was fixed in place with acrylic dental cement and one anchoring skull screw. After 30 min, a dummy cannula (C315DC/SPCA, cut length, 1 mm extension) was twisted onto the guided cannula. Mice were allowed to recover for 1 week, monitoring food intake and body weight. Mice with abnormal food intake or body weight were excluded. Mice were handled daily and habituated to the injection procedure for 5 days before experimental procedures. At the day of experiment, mice were held gently, while the dummy cannula was removed and the internal cannula (C315IA/SPC, 33 gauge, 8 mm pedestal size, cut length, 1 mm extension) was inserted. The internal cannula was connected to a plastic tube containing a Hamilton syringe at its end, allowing free movement of mice during injection. For PVN, NALO (5 mg per 0.5 ml saline, injection time 1 min) was injected 5 min before peripheral (intraperitoneal) injection of ACEA or WIN. For ARC, ACEA (1 mg per 0.5 ml saline (10% DMSO, 0.2% Tween-80); 1 min) was added. RIMO (1.25 mg per 0.5 ml saline (25% DMSO, 0.2% Tween-80); 1 min) was injected 5 min before peripheral (intraperitoneal) injection of ACEA or WIN. Internal cannula was kept in brain for another minute before replacement and, finally, dummy cannula was twisted onto guided cannulas and food intake was monitored for 1 and 2 h. In previous experiments equal volume injection of the fluorescent dye Hoechst 33342 (1:10 in saline) into the PVN or ARC was identified as an ideal spread of injection. After finishing food intake experiments, Hoechst 33342 was also used to assess correct cannula placement. Mice with missed target areas were excluded. Stereotaxic virus injection. Animals were injected as described earlier 3, 53 . In brief, bilateral virus injections were made into the ARC of anaesthetized (see 'central cannula placement') 12-week-old male Pomc-Cre mice, placed into a stereotaxic apparatus (model 902; David Kopf instruments). Viruses (200 nl) containing the inhibitory DREADD (rAAV5/EF1a-DIO-hM4Di-mCherry) or the stimulating DREADD (rAAV5/EF1a-DIO-hM3Dq-mCherry) were applied into each hemisphere (coordinates: bregma, anterior-posterior: 21.2 mm, dorsal-ventral: 25.8 mm, lateral: 60.3 mm) by using an air pressure system (injection time 5 min). After surgery, mice were allowed to recover for 1 week and were then acclimated for food intake experiments (see 'food intake measurements'). After finishing the feeding experiments, mice were transcardially perfused and 50-mm-thick vibratome sections of the ARC were prepared. Accurate virus injection into the ARC was verified by analysing local mCherry fluorescence. Mice with 'missed' or 'partial' hits were excluded. Specific (virus) expression in ARC POMC neurons was signified by double fluorescence labelling for mCherry and POMC (see 'immunofluorescence').
Food intake measurements. One week before starting experiments, animals were allowed to habituate to single cage housing. Sham injections were performed 2 days before starting the experiment. The day before experiment, single home cages were changed to avoid mice eating food that may have been deposited in the bedding of the cages. To generally minimize disposal of food, the animals were adapted to lower amounts of food (15-25 g per cage) at starting adaption to single housing. To analyse the effect of the CB 1 R agonist ACEA or the CBR agonist WIN on food intake in fed animals, food was removed, new pre-weighed food pellets were applied and food intake of each single-housed animal was measured 1, 2 and 24 h after intraperitoneal injection of ACEA or WIN, compared to vehicle, respectively (injection time: 09:00). In the DREADD feeding experiments, CNO (0.3 mg kg 21 body weight; intraperitoneal) was injected 15 min before cannabinoid (ACEA or WIN) treatment. To investigate whether cannabinoid (ACEA or WIN)-induced feeding is mediated via b-endorphin release, the m-opioid receptor antagonist naloxone (7.5 mg kg 21 body weight; intraperitoneal) was injected 15 min before cannabinoid (ACEA or WIN) administration and food intake was analysed 1 h after injection. To address the question whether CB 1 R inverse agonist RIMO reduced fasting-induced refeeding, the single-housed animals were fasted overnight before intraperitoneal injection of 3 mg kg 21 RIMO or vehicle (injection time: 09:00). Fifteen minutes after RIMO injection, a pre-weighed amount of food was placed into the cage and the food intake was then calculated for 1, 2 and 24 h. At all times the cages were inspected for food spillage and those mice in cages with visible food deposits in the bedding were excluded from the studies. Radioimmunoassay. Male C57BL6 mice were killed by decapitation and brains were immediately removed. A block of the hypothalamus was cut and a 2-mm slice of the mediobasal forebrain was made using a Leica VT1000P vibratome. Each slice was first incubated with aCSF in an incubator (37 uC, 95% O 2 and 5% CO 2 ) for 1 h. This was followed by another incubation in aCSF, followed by incubation in aCSF (control) or in aCSF containing 100 nM ACEA (both groups containing 56 mM KCl) for 45 min. The supernatant was then removed and frozen for future RIA analysis. The a-MSH and b-endorphin radioimmunoassays were performed following instructions of the Phoenix pharmaceutical RIA kit (a-MSH, RK-043-01; b-endorphin, RK-022-33). ELISA. Ex vivo measurements of b-endorphin content in mediobasal hypothalamus derived from male wild-type and corresponding Cnr1 2/2 littermates was assessed by use of a commercially available b-endorphin ELISA kit and in accordance to manufacturer's instructions (MyBioSource, MBS703919). In brief, 30 mg of tissue was rinsed and mechanically homogenized in PBS. After two freezethaw cycles, the homogenates were centrifuged for 5 min at 5,000g and 4 uC. The supernatant was removed and assayed immediately. In parallel, sample protein concentrations were measured using the BCA kit (Thermo scientific, 23228 and 1859078), and b-endorphin content was calculated as nanograms b-endorphin per milligram protein. qPCR and western blot analyses. Food was removed from cages of fed mice. Male C57BL6 mice were then treated with vehicle or ACEA (1 mg kg 21 body weight, intraperitoneal) as described above. After 90 min, the mediobasal hypothalamus was rapidly collected and snap frozen in liquid nitrogen. Total RNA was extracted using TRIzol (Life Technologies) according to manufacturer's instructions. cDNA was synthesized by First-Strand cDNA Kit (Amersham Biosciences) following the manufacturer's instructions. Real-time PCR (Light Cycler 480 System, Roche) was performed using TaqMan gene expression assay for Psck1, Pcsk2, Ucp2 and Cnr1 (Mm00479023_m1, 4331182; Mm00500981_m1, 4331182; Mm00627599_m1, 4331182; Mm01212171_s1, 4331182; Life Technologies). b-actin (mouse Actb, 4352341; Life Technologies) was used as housekeeping gene.
Micro-punched ARC from fed male C57BL6 mice, either treated with vehicle or ACEA (1 mg kg 21 body weight, intraperitoneal) for 90 min after removal of food, were isolated and lysed in modified RIPA buffer (50 mM Tris-HCl, pH 7.5; 150 mM NaCl, 1 mM EDTA, 1% NP-40, 0.1% SDS, 1 mM PMSF), supplemented with protease inhibitor cocktail (Roche, 11 836 170 001), on ice for 30 min followed by centrifugation at 14,000 r.p.m. for 15 min. Protein concentrations were measured using the BCA kit (Thermo Scientific). Proteins were resolved on 8% SDS-PAGE and transferred to PVDF membrane (Millipore, IPVH 15150). Membranes were blocked with 5% dry milk in TBS (50 mM Tris-HCl, pH 7.5; 150 mM NaCl) for 1 h and then followed by overnight incubation at 4 uC with first antibodies (see Supplementary Table 1) . After three washes with TBST (TBS plus 0.05% Tween 20), membranes were incubated with anti-rabbit IgG conjugated to horseradish peroxidase (Santa Cruz Biotechnology, sc-2004) for 1 h and developed by ECL kit (Thermo Scientific, 32016). Membranes were reused to detect b-actin (see Supplementary Table 1 ) after stripping with Restore PLUS Western Blot stripping buffer (46430, Thermo Fisher Scientific). The relative protein amount of PC-1, PC-2 and POMC in each sample was calculated from the respective b-actin immunosignal. ROS measurement. After removal of food at 10:00, fed age-and weight-matched littermates of male and female Pomc-GFP mice were injected with vehicle or 1 mg kg 21 ACEA (intraperitoneal) for 90 min. DHE (10 mg) was dissolved in 200 ml DMSO 5 min before injection and kept light-protected at room temperature. Then 240 ml of warm (42 uC) PBS was slowly mixed with 60 ml DHE solution, and 200 ml of the DHE solution (1 mg ml 21 in 20% DMSO) was injected via the tail vein 45 min before the animals were anaesthetized by isofluorane and killed by perfusion fixation (4% PFA in 0.1 M PBS). After post-fixation in 4% PFA overnight, the brains were washed in PBS for 30 min and coronal brain sections (50 mm) of the ARC were obtained using a Leica VT1000P vibratome (Leica Microsystems). The slices were mounted on glass slides and coverslipped using DAKO fluorescence mounting medium (Dako North America) and kept at 4 uC for no longer than 1 day. Confocal images were taken by use of an Olympus FV 300 Laserscanning microscope. Semi-quantitative analysis of the DHE signal in Pomc-GFP labelled cells was performed by determine the mean dens area of the DHE signal in the respective GFP positive neuron, using imagej 1.48 s software (Rasband, W.S., ImageJ, US National Institutes of Health). To avoid false-positive results, the autofluorescence in animals that were injected with saline instead of DHE was subtracted from the DHE-obtained values. Brain tissue fractionation. Mouse brain homogenates were purified using a differential centrifugation method described earlier 54 . After removal of food from cages, mice were injected with vehicle or ACEA for 90 min. For isolation of mitochondria-enriched fractions, male and female C57BL6, Ucp2 2/2 and corresponding wild-type littermates were killed and both the hippocampus and the hypothalamus were immediately dissected from brains and put on ice. Tissue was manually homogenized at 4 uC in 10 ml of isolation buffer containing 225 mM mannitol, 75 mM sucrose, 5 mM HEPES, 1 mM EGTA, 1 mg ml 21 BSA and 0.3125 mg ml 21 protease type VIII (Sigma-Aldrich) at pH 7.4. The homogenate was brought to 20 ml final volume and centrifuged at 2,000g for 5 min. The pellet, including the synaptosomal layer was re-suspended in 10 ml of the isolation buffer now containing 0.02% (w/v) digitonin and centrifuged at 12,000g for 10 min. The pellet without the synaptosomal layer was re-suspended in 10 ml of isolation buffer and centrifuged at 12,000g for 10 min. The pellet was finally resuspended in 50 ml of a buffer containing 225 mM mannitol, 75 mM sucrose, 5 mM HEPES at pH 7.4. Ex vivo mitochondrial respiration. Protein concentrations of mitochondrial preparations were determined with a BCA protein assay kit (Perbio). For mitochondrial respiration analyses, 0.5 mg ml 21 protein was added into the reaction chamber of a Clark type oxygen electrode (Hansatech Instruments) which has been set to 37 uC and filled with 1 ml respiration buffer (100 mM sucrose, 5 mM HEPES, 100 mM KCl, 2 mM KH 2 PO 4 and 10 mM EGTA, pH 7.4). Pyruvate (5 mM) and malate (2.5 mM) were then added concomitantly as the oxidative substrates.
To determine ADP-dependent (state 3) respiration, ADP (2.5 mM) was added. After the ADP was exhausted, oligomycin (1 mM) was applied to analyse respiration independently of phosphorylation (state 4 activity). Statistics. Statistical analyses were performed by use of Prism 6.0 software (Graph Pad). P , 0.05 was considered statistically significant. P values for unpaired comparisons between two groups were calculated by two-tailed Student's t-test. Oneway ANOVA, followed by Dunnett's multiple comparisons test (all groups against vehicle-treated control group) was used for comparisons between three or more groups. Ordinary two-way ANOVA, followed by Šidák's multiple comparison test was used to examine how food intake was affected by two factors. Interactions between the following treatments were tested: CNO against ACEA or WIN; RIMO against ACEA or WIN; NALO against ACEA or WIN; ACEA treatment against genotype (wild-type littermates versus Ucp2 2/2 mice). *P , 0.05, **P , 0.01, ***P , 0.001. Error bars indicate mean 6 s.e.m. No statistical methods were used to predetermine sample size.
Extended Data Figure 5 | Post-transcriptional regulation of hypothalamic pro-protein convertases, normal Cnr1 expression in Ucp2 2/2 mice and presence of CB 1 R in POMC neurons. a, b, ACEA did not affect transcripts of pro-protein convertases 1 (Pcsk1) and 2 (Pcsk2) (in fold change; Pcsk1: vehicle, n 5 11 mice, 1.00 6 0.07; ACEA, n 5 10 mice, 1.17 6 0.09; Pcsk2: vehicle, n 5 11 mice, 1.00 6 0.13; ACEA, n 5 11 mice, 1.14 6 0.19; P . 0.05; two independent experiments). c, Representative western blot membranes for PC-1 (,80 kilodaltons (kDa)) and PC-2 (,72 kDa) immunolabelling. d, Equal Cnr1 expression in wild-type and Ucp2 2/2 mice (in fold change: all groups n 5 6 mice; wild type, 1.00 6 0.1; Ucp2 2/2 , 0.98 6 0.12; P . 0.05). e, We have previously shown that antibodies raised against CB 1 R also recognized the mitochondrial protein, stomatin-like protein 2 (ref. 21) . In line with this, mitochondrial labelling of CB 1 R was found substantially diminished but not completely eliminated in CB 1 R-KO (Cnr1 2/2 ) mice [23] [24] [25] . We observed that in contrast to wild-type animals (Cnr1 1/1 mice), which showed ,80% (77 out of 97, 79.5 6 3.9%) of POMC neurons (red fluorescence) to contain labelling with the CB 1 R antisera (green fluorescence), in CB 1 R knockout (KO; Cnr1 2/2 ) mice, less than 30% (37 out of 128, 29.2 6 3.3%) of POMC neurons retained immunolabelling. Thus, we concluded that a large population of POMC neurons contains CB 1 R (***P , 0.001). All values (biological replicates: a-c, d; biological replicates including technical replicates: e) denote mean 6 s.e.m. If not otherwise stated, P values (unpaired comparisons) by two-tailed Student's t-test. Scale bar, 25 mm.
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